HIGHLIGHTS
- who: Pashalina Kehagias and collaborators from the Laboratory of Clinical and Experimental Oncology, Institut Jules Bordet, Universitu00e9 Libre de Bruxelles (ULB) have published the article: Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance, in the Journal: Cells 2022, 11, x FOR PEER REVIEW of /2022/
- what: The authors explored the effects of short and long-term regorafenib exposure on representative human CRC cell lines to identify resistance mechanisms to this MKI. 8 of 20 Following these indications, the authors aimed to identify changes in the proportion of cells in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.